Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shun Lu

Showing results (411-420 of 661) with videos related to

Pageof 67
Sort By:
JTO Clinical and Research Reports|September 30, 2021
Efficacy and Safety of S-1 Compared With Docetaxel in Elderly Patients With Advanced NSCLC Previously Treated With Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC TrialJames Chih-Hsin Yang, Tony S K Mok, Shun Lu, et al.
Chinese Medical Journal|April 17, 2025
Clinical practice guidelines for perioperative multimodality treatment of non-small cell lung cancerWenjie Jiao, Liang Zhao, Jiandong Mei, et al.
Journal of Surgical Oncology|June 20, 2012
Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patientsYi Yang, Zhen Zhou, Xiao-Min Niu, et al.
Journal of Raman Spectroscopy : JRS|April 6, 2021
An efficient primary screening of COVID-19 by serum Raman spectroscopyGang Yin, Lintao Li, Shun Lu, et al.
Cytokine|November 8, 2020
Single nucleotide polymorphisms within NFKBIA are associated with nasopharyngeal carcinoma susceptibility in Chinese Han populationHanyi Zhang, Siyao Deng, Jiayu Zhang, et al.
Frontiers in Immunology|September 17, 2025
Single-cell RNA-seq reveals a repair pattern in cystic lesions in steroid induced osteonecrosis of the femoral headPeng Peng, Jiaqing Tian, Kun Lin, et al.
Future Oncology (London, England)|December 16, 2021
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancerByoung Chul Cho, Enriqueta Felip, Hidetoshi Hayashi, et al.
Journal of Cellular and Molecular Medicine|February 26, 2015
17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathwayXiang-Yun Ye, Qing-Quan Luo, Yun-Hua Xu, et al.
Oncology Letters|May 15, 2025
Prophylactic cerebral irradiation sensitizes relapsed sensitive small cell lung cancer to temozolomide: A retrospective cohort studyDan He, Shuxia Wei, Fenghao Geng, et al.
Clinical Lung Cancer|May 30, 2016
Meta-Analysis of First-Line Pemetrexed Plus Platinum Treatment in Compared to Other Platinum-Based Doublet Regimens in Elderly East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung CancerShun Lu, Ying Cheng, Cai-Cun Zhou, et al.
Pageof 67

Showing results (411-420 of 661) with videos related to

Sort By:
Pageof 67
JTO Clinical and Research Reports|September 30, 2021
Efficacy and Safety of S-1 Compared With Docetaxel in Elderly Patients With Advanced NSCLC Previously Treated With Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC TrialJames Chih-Hsin Yang, Tony S K Mok, Shun Lu, et al.
Chinese Medical Journal|April 17, 2025
Clinical practice guidelines for perioperative multimodality treatment of non-small cell lung cancerWenjie Jiao, Liang Zhao, Jiandong Mei, et al.
Journal of Surgical Oncology|June 20, 2012
Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patientsYi Yang, Zhen Zhou, Xiao-Min Niu, et al.
Journal of Raman Spectroscopy : JRS|April 6, 2021
An efficient primary screening of COVID-19 by serum Raman spectroscopyGang Yin, Lintao Li, Shun Lu, et al.
Cytokine|November 8, 2020
Single nucleotide polymorphisms within NFKBIA are associated with nasopharyngeal carcinoma susceptibility in Chinese Han populationHanyi Zhang, Siyao Deng, Jiayu Zhang, et al.
Frontiers in Immunology|September 17, 2025
Single-cell RNA-seq reveals a repair pattern in cystic lesions in steroid induced osteonecrosis of the femoral headPeng Peng, Jiaqing Tian, Kun Lin, et al.
Future Oncology (London, England)|December 16, 2021
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancerByoung Chul Cho, Enriqueta Felip, Hidetoshi Hayashi, et al.
Journal of Cellular and Molecular Medicine|February 26, 2015
17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathwayXiang-Yun Ye, Qing-Quan Luo, Yun-Hua Xu, et al.
Oncology Letters|May 15, 2025
Prophylactic cerebral irradiation sensitizes relapsed sensitive small cell lung cancer to temozolomide: A retrospective cohort studyDan He, Shuxia Wei, Fenghao Geng, et al.
Clinical Lung Cancer|May 30, 2016
Meta-Analysis of First-Line Pemetrexed Plus Platinum Treatment in Compared to Other Platinum-Based Doublet Regimens in Elderly East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung CancerShun Lu, Ying Cheng, Cai-Cun Zhou, et al.
Pageof 67